Jeff Richgels
No date has been set, but TomoTherapy's initial public offering of stock could be drawing near.
The Madison-based tech company on Thursday filed an amended registration statement with the U.S. Securities and Exchange Commission indicating that it could raise up to $213 million in its IPO. The company has applied to be listed on the Nasdaq Global Market under the symbol "TTPY."
TomoTherapy says its "Hi-Art" cancer treatment system precisely delivers radiation with sub-millimeter accuracy to kill cancer cells while reducing radiation exposure to surrounding healthy tissue. The company has about 500 employees and has said it plans to add another 100 this year.
